Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Candel Therapeutics (NASDAQ: CADL), Inc. Highlights $201.6M Cash and 2028 Runway

Its September 2026 investor presentation highlights clinical progress for aglatimagene besadenovec and linoserpaturev, two programs designed to support cancer treatment development.

Vinay Lochav | 10 September 2026

Cardiol Therapeutics Inc. (NASDAQ: CRDL) Sets Sept. 14 Fireside Chat

The event gives investors access to a live webcast through the company’s investor website as Cardiol (NASDAQ: CRDL) advances therapies for inflammatory and fibrotic heart disease.

Vinay Lochav | 10 September 2026

Aquestive Therapeutics (NASDAQ: AQST) CEO Records 91,743-Share Code X Transaction at $0.96

Aquestive Therapeutics, Inc. (NASDAQ: AQST) President and CEO Barber Daniel recorded a code X transaction involving 91,743 shares at $0.96 per share on September 8, 2026. His resultingEquityposition stood at 677,317 shares. Barber’s resulting derivative securities position was 0.

Vinay Lochav | 10 September 2026

Ridgetech (NASDAQ: RDGT) Authorized Share Capital Remains US$36.01 Million After Capital Reduction

The changes became effective on September 2 afterShareholderapproval on August 25 and registration confirmation from the Cayman Islands Registrar of Companies on September 7.

Vinay Lochav | 10 September 2026

RoyaLand Highlights 23.2-Year Savoia Squad, Targets Serie A

RoyaLand Co Ltd. (OTC: RLNDF) is advancing Savoia 1908 FC’s professional-football project with a squad valued at approximately €3.88 million and a stated objective of securing its position in Serie C. The BermudaHolding Companysays the club’s longer-term strategy is to develop young players, build …

Vinay Lochav | 10 September 2026

Tarsus Pharmaceuticals COO Sells 4,564 Shares at $85 (NASDAQ: TARS)

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) shares were sold by Chief Operating Officer Neervannan Seshadri at $85 per share, with 4,564 shares changing hands.

Vinay Lochav | 10 September 2026

TAT Technologies (NASDAQ: TATT) Shareholders Approve All 2026 Meeting Proposals

TAT TECHNOLOGIES LTD (NASDAQ: TATT) received approval for every proposal presented at its 2026 annual general meeting, with approximately 72% of its outstanding ordinary shares represented and voted. The meeting outcome covers the proposals included in the company’s proxy materials.

Vinay Lochav | 10 September 2026

Where Food Comes From Corrects 2025 Lease Controls Weakness (NASDAQ: WFCF)

Where Food Comes, Inc. (NASDAQ: WFCF) determined that its disclosure controls were ineffective as of December 31, 2025, after identifying a material weakness in lease accounting. Management said the weakness involved the improper application of FASB ASC 842 and resulted in material overstatements of …

Vinay Lochav | 10 September 2026

Wing Yip (NASDAQ: WYHG) CEO’s Resulting Stake Reaches 16,233,007 Shares

Wing Yip Food Holdings Group Ltd (NASDAQ: WYHG) awarded Chief Executive Officer Wang Tingfeng 13,000,000 shares. The transaction was recorded on 7 September 2026.

Vinay Lochav | 10 September 2026

Adagene Inc. (NASDAQ: ADAG) Wins $2M Exelixis Milestone for XB404

Adagene Inc. (NASDAQ: ADAG) reached a preclinical milestone for XB404 in its collaboration with Exelixis, generating a $2.0 million payment. The SAFEbody-built antibody-drug conjugate candidate is designed to target tumors expressing ROR1/2 while limiting effects on healthy tissue.

Vinay Lochav | 10 September 2026
Support

Hi! How can we help you today?

Loading…